BCIDP Board Certified Infectious Disease Pharmacist Exam Practice Test
The Board Certified Infectious Diseases Pharmacist (BCIDP) credential is the premier certification validating specialized expertise in antimicrobial stewardship, infection prevention, and the pharmacotherapy of complex infectious diseases. Awarded by the Board of Pharmacy Specialties (BPS), this certification signifies that a pharmacist has demonstrated the advanced knowledge and clinical judgment required to optimize patient outcomes in infectious disease management. BCIDP-certified pharmacists are recognized leaders in developing and implementing antimicrobial stewardship programs (ASPs), managing infections in immunocompromised hosts, interpreting diagnostic microbiology, and navigating the challenges of antimicrobial resistance. This credential is essential for pharmacists practicing in acute care, academia, public health, and research who are responsible for guiding evidence-based antimicrobial use, reducing healthcare-associated infections, and contributing to the global fight against multidrug-resistant organisms. Achieving BCIDP status distinguishes a pharmacist as a top-tier expert, directly impacting patient safety, institutional quality metrics, and public health initiatives.
Sample Questions
Try a few questions to see what the full exam is like.
45 of 140 answers carry a checkable reference.
A 71-year-old with Enterococcus faecalis native-valve endocarditis has an isolate susceptible to ampicillin and ceftriaxone synergy. Baseline creatinine clearance is 32 mL/min, and the team proposes ampicillin plus gentamicin for 6 weeks. Which regimen best reduces toxicity while preserving synergy?
A patient with hospital-acquired pneumonia has Acinetobacter baumannii-calcoaceticus complex resistant to carbapenems and susceptible to sulbactam-durlobactam. The team asks why the regimen includes sulbactam rather than tazobactam. Which explanation is best?
A 59-year-old with acute myeloid leukemia has febrile neutropenia, hypotension, and a history of ESBL Klebsiella bacteremia 2 months ago. He is taking levofloxacin prophylaxis. There is no catheter erythema, pneumonia, or skin infection. Which empiric approach is most appropriate while cultures are pending?
A ranch worker with a prosthetic valve has months of fevers, negative routine blood cultures, hepatitis, and serology strongly positive for Coxiella burnetii phase I IgG. Which epidemiologic and diagnostic point is most relevant?
A 72-year-old with severe community-acquired pneumonia is started on ceftriaxone plus azithromycin. Two hours later, urine Legionella antigen is positive. QTc is 535 ms, potassium is 3.1 mEq/L, and he takes amiodarone. Which pharmacist recommendation best balances efficacy and safety?
Career Opportunities & Salary
Why This Certification Opens Doors
Earning the BCIDP credential is a definitive career milestone that establishes your authority in a critical and rapidly evolving specialty. It provides formal, industry-wide recognition of your advanced competencies, setting you apart in a competitive job market. This certification is increasingly required or preferred for leadership roles in antimicrobial stewardship programs, infectious disease consult services, and clinical coordinator positions. It validates your expertise to hospital administrators, healthcare teams, and patients, enhancing your professional credibility and influence in shaping institutional protocols and national guidelines. For the pharmacy profession, BCIDP certification elevates the standard of care in infectious diseases and demonstrates the indispensable role of pharmacists in improving antimicrobial use and combating resistance.
Exam Blueprint
Each domain is weighted to match the real certification exam, so a full practice simulation predicts your result.